Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-09-10Clinical Trial Update: Evaluation of Patients With Non-cardiac Chest Pain [Phase 4]
Phase 4 clinical trial update examining evaluation of patients with non-cardiac chest pain and gastroesophageal reflux disease; the study st…
-
CLINICAL_TRIALS trial_result · 2009-08-28Clinical Trial Update: Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive Esophagitis [Phase 3]
Phase 3 trial comparing dexlansoprazole MR to placebo to maintain healing in subjects with healed erosive esophagitis; results posted in 200…
-
CLINICAL_TRIALS trial_result · 2009-08-28Clinical Trial Update: Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Dexlansoprazole MR vs placebo in maintaining healing in patients with healed erosive eso…
-
CLINICAL_TRIALS trial_result · 2009-08-28Clinical Trial Update: Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive Esophagitis [Phase 3]
Phase 3 trial evaluating dexlansoprazole MR for maintaining healing in subjects with previously healed erosive esophagitis; results and safe…
-
CLINICAL_TRIALS trial_result · 2009-08-12Clinical Trial Update: Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn [Phase 3]
Phase 3 safety and quality-of-life results for a dexlansoprazole modified-release formulation in gastroesophageal reflux disease have been p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-08-06Clinical Trial Update: National Survey on Gastroesophageal Reflux Disease (GERD) Patients
A completed AstraZeneca-sponsored clinical trial survey evaluating patients with gastroesophageal reflux disease (GERD).
-
CLINICAL_TRIALS trial_result · 2009-07-13Clinical Trial Update: An Evaluation of the Medtronic Gatekeeper System in the Treatment of SUBJECTS With Gastroesophageal Reflux Disease (GERD) [NA]
A clinical trial evaluating the Medtronic Gatekeeper System for treating gastroesophageal reflux disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-05-13Clinical Trial Update: Role of Mosapride in Patients With Gastroesophageal Reflux Disease [Phase 4]
A Phase 4 trial evaluating mosapride for gastroesophageal reflux disease has completed.
-
CLINICAL_TRIALS trial_result · 2009-05-08Clinical Trial Update: Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD) [Phase 2]
Phase 2 trial evaluating rabeprazole in subjects with gastroesophageal reflux disease has completed. The study was conducted under sponsorsh…
-
CLINICAL_TRIALS trial_result · 2009-04-22Clinical Trial Update: Diagnostic Efficacy of Narrow Band Imaging in Patients With Gastroesophageal Reflux Disease
The document reports the completion of a clinical trial evaluating the diagnostic efficacy of narrow-band imaging for diagnosing gastroesoph…
-
CLINICAL_TRIALS trial_result · 2009-04-10Clinical Trial Update: Pharmacokinetics of Enteral Omeprazole Suspension in Patients With Cerebral Palsy and Mental Retardation [Phase 2]
A Phase 2 pharmacokinetic study of an enteral omeprazole suspension in patients with cerebral palsy and mental retardation evaluating the dr…
-
CLINICAL_TRIALS trial_result · 2009-03-31Clinical Trial Update: Nissen and Gastroplasty in Gastroesophageal Reflux Disease (GERD) [Phase 4]
This update notes the completion of a Phase 4 clinical trial evaluating Nissen fundoplication and gastroplasty for gastroesophageal reflux d…
-
CLINICAL_TRIALS trial_result · 2009-03-26Clinical Trial Update: NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis [Phase 4]
Phase 4 trial update completed evaluating Nexium (esomeprazole) for moderate to severe erosive esophagitis and related reflux conditions.
-
CLINICAL_TRIALS trial_result · 2009-03-26Clinical Trial Update: HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related Disease [Phase 3]
Phase 3 HEARD long-term study evaluating histology of the esophagus in acid-related disease has completed, sponsored by AstraZeneca.
-
CLINICAL_TRIALS trial_result · 2009-03-23Clinical Trial Update: Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Heartburn [Phase 3]
Phase 3 trial update evaluating safety and efficacy of a modified-release formulation of dexlansoprazole for heartburn due to gastroesophage…
-
CLINICAL_TRIALS trial_result · 2009-03-23Clinical Trial Update: Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux Disease [Phase 3]
Phase 3 trial results update on the safety and efficacy of a modified-release formulation of dexlansoprazole for gastroesophageal reflux dis…
-
CLINICAL_TRIALS trial_result · 2009-03-23Clinical Trial Update: Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Dexlansoprazole MR and Lansoprazole for healing erosive esophagitis; results have been p…
-
CLINICAL_TRIALS trial_result · 2009-03-23Clinical Trial Update: Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat Heartburn [Phase 3]
Phase 3 results report the efficacy and safety of a modified-release formulation of dexlansoprazole for gastroesophageal reflux disease (hea…
-
CLINICAL_TRIALS trial_result · 2009-03-23Clinical Trial Update: Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Dexlansoprazole MR and Lansoprazole for healing erosive esophagitis; results were posted…
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD) [Phase 4]
Phase 4 multicenter randomized trial comparing esomeprazole 20 mg and 40 mg daily to placebo for heartburn and sleep disturbances in gastroe…
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: Validation of RDQ Questionnaire [Phase 4]
Phase 4 study validating the Reflux Disease Questionnaire (RDQ) for gastroesophageal reflux disease has completed. The results support its u…
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD) [Phase 3]
A Phase 3 multicenter randomized trial evaluating esomeprazole 20 mg once daily versus placebo for the resolution of upper abdominal pain in…
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: ASTERIX: Low Dose ASA and Nexium [Phase 3]
Phase 3 trial ASTERIX investigating low-dose aspirin and esomeprazole for gastroesophageal reflux disease has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-11Clinical Trial Update: Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD [Phase 4]
Phase 4 clinical trial evaluating 24-hour intragastric pH profiles after administration of esomeprazole, lansoprazole, and pantoprazole in H…
-
CLINICAL_TRIALS trial_result · 2009-03-11Clinical Trial Update: PPI Sequencing Study [Phase 4]
A Phase 4 clinical trial evaluating proton pump inhibitor sequencing for gastroesophageal reflux disease sponsored by AstraZeneca has comple…